About Xenetic Biosciences Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.xeneticbio.com/
Frequently Asked Questions
What is the 52-week range for XBIO?
The 52-week high is $13.93 and the 52-week low is $1.87.
What is the P/E ratio for XBIO?
The P/E ratio data is currently unavailable.
What is the dividend yield for XBIO?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -40.62%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -75.91%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.67.
Analyst Recommendation Trends
Wall Street analyst consensus for XBIO over the last few months:
Latest XBIO News
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular session. The company's market cap stands at $1.1 million. Greenland Mines (NASDAQ:GRML) shares moved upwards by
Xenetic Biosciences Announces All-Stock Merger with Santersus, Leaving Existing Shareholders with 15% Stake
The proposed transaction would create a Nasdaq-listed company focused on NET-targeting therapies, combining four clinical programs while transferring majority ownership to Santersus shareholders. Key Investor TakeawaysXenetic Biosciences (NASDAQ:XBIO) has signed a definitive share exchange agreement to acquire privately held Santersus AG in an all-stock transaction.
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
Xenetic Biosciences Inc. (NASDAQ:XBIO) on Wednesday struck a definitive share exchange agreement to purchase Santersus AG, a privately held therapeutic medical device firm advancing its selective blood purification platform. The all-stock deal hinges on shareholder approval and involves exchanging newly issued Xenetic shares for all outstanding Santersus equity. Following the transaction, the unified entity plans to rebrand as Santersus Bio, Inc. and trade on the Nasdaq Capital Market under the
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 354.9% to $7.37 during Wednesday's regular session. The company's market cap stands at $4.9 million. Q/C Technologies (NASDAQ:QCLS) shares increased by
Crude Oil Down Over 3%; US Business Inventories Surge In July
U.S. stocks mixed: Dow slipped 0.1%, Nasdaq rose 0.7%, S&P 0.3%; tech led gains, energy fell, while oil dropped 3.2%.
Xenetic Biosciences, Inc. (XBIO) M&A Call Prepared Remarks Transcript
Xenetic Biosciences, Inc. (XBIO) M&A Call September 16, 2026 8:30 AM EDTCompany ParticipantsJames Parslow - CFO, COO, Interim CEO & Corporate...
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
The combined company is expected to continue to trade on the Nasdaq Capital Market as Santersus Bio, Inc."The Proposed Transaction is expected to create a Nasdaq-listed, multi-indication clinical-stage company focused on a single high-impact therapeutic target: neutrophil extracellular traps, or NETs.
Nasdaq Gains Over 100 Points; US Retail Sales Beat Estimates
U.S. stocks edged higher as strong retail sales lifted sentiment; utilities gained, energy fell, oil dropped, while European and Asian markets advanced.
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market session. The company's market cap stands at $4.9 million. Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-04-21 | PARSLOW JAMES F | +100,000 | - | - |
| 2025-12-31 | VINOGRADOV ALEXEY ANDREEVICH | +2,500 | - | - |
| 2025-12-31 | Dastoor Firdaus J. | +2,500 | - | - |
| 2025-12-31 | Borisenko Grigory G. | +2,500 | - | - |
| 2025-12-31 | Kornberg Roger D. | +2,500 | - | - |